US lawmakers continue to increase funding for surprise and in-person facility inspections by the Food and Drug Administration, but they warned the agency that the money should be used as intended.
The fiscal year 2022 omnibus appropriations package, which cleared the House on 9 March, includes an additional $5m for...






